Roth Capital Weighs in on Fortress Biotech, Inc.’s Q3 2024 Earnings (NASDAQ:FBIO)
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Roth Capital raised their Q3 2024 EPS estimates for shares of Fortress Biotech in a note issued to investors on Wednesday, August 14th. Roth Capital analyst J. Wittes now forecasts that the biopharmaceutical company will post earnings per share of ($0.27) for the quarter, up from their […]
More Stories
SPDR S&P Transportation ETF (NYSEARCA:XTN) Shares Up 0.3% – What’s Next?
SPDR S&P Transportation ETF (NYSEARCA:XTN – Get Free Report)’s share price rose 0.3% during mid-day trading on Wednesday . The...
A10 Networks, Inc. (NYSE:ATEN) EVP Sells $102,905.40 in Stock
A10 Networks, Inc. (NYSE:ATEN – Get Free Report) EVP Karen S. Thomas sold 6,162 shares of the company’s stock in...
Jeffrey Westphal Sells 2,485,000 Shares of Vertex, Inc. (NASDAQ:VERX) Stock
Vertex, Inc. (NASDAQ:VERX – Get Free Report) major shareholder Jeffrey Westphal sold 2,485,000 shares of the company’s stock in a...
Branicks Group AG (OTCMKTS:DDCCF) Short Interest Update
Branicks Group AG (OTCMKTS:DDCCF – Get Free Report) was the recipient of a significant decline in short interest during the...
Short Interest in Colruyt Group (OTCMKTS:CUYTY) Decreases By 63.3%
Colruyt Group (OTCMKTS:CUYTY – Get Free Report) saw a large decline in short interest in the month of October. As...
Torstar (OTCMKTS:TORSF) Trading Down 1.3% – Should You Sell?
Torstar Co. (OTCMKTS:TORSF – Get Free Report) shares traded down 1.3% during mid-day trading on Wednesday . The company traded...